<?xml version="1.0" encoding="UTF-8"?>
<p>Considering that the advent of HCV curative therapies, potential exists to eliminate HCV infection from U.S. communities. For this reason, identification of persons unaware of their HCV infection has become a public health priority. Because of the increasing incidence of HCV infection among persons who inject drugs, testing and treatment of this population is needed for both infection prevention and for ending the HCV infection epidemic. Although recent studies of ED-based, targeted hepatitis C testing have highlighted the high prevalence of positive results for anti-HCV among the 1945–1965 birth cohort (10.3%–11.6%), ED-based programs have been challenged to systematically identify and test an increasing number of younger persons who inject drugs (
 <xref rid="R5" ref-type="bibr">
  <italic>5</italic>
 </xref>,
 <xref rid="R6" ref-type="bibr">
  <italic>6</italic>
 </xref>,
 <xref rid="R9" ref-type="bibr">
  <italic>9</italic>
 </xref>,
 <xref rid="R10" ref-type="bibr">
  <italic>10</italic>
 </xref>).
</p>
